ORAMED PHARMACEUTICALS INC. (ORMP)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, ORAMED PHARMACEUTICALS INC. reported revenue of $2.00M. The company was profitable, with a net margin of 3202.5% and a gross margin of 0.7%.
Key ratios (FY2025)
0.7%
Gross margin
-754.4%
Operating margin
3202.5%
Net margin
32.1%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.00M | — | $1.34M | $2.70M | $2.70M | $2.71M | $2.70M | $2.45M | $2.46M | $641.0K |
| Cost of Revenue | $1.99M | — | — | — | — | — | $90.0K | -$86.0K | $187.0K | $490.0K |
| Gross Profit | $13.0K | — | — | — | — | — | — | — | — | — |
| Operating Income | -$15.09M | -$12.78M | -$15.77M | -$40.60M | -$24.22M | -$11.76M | -$14.63M | -$13.53M | -$10.77M | -$10.01M |
| Net Income | $64.05M | -$19.06M | $5.09M | -$36.56M | -$22.99M | -$11.51M | -$14.36M | -$12.73M | -$10.48M | -$10.96M |
| EPS (Diluted) | $1.50 | $-0.48 | $0.14 | $-0.94 | — | — | — | — | — | — |
| Total Assets | $230.86M | $155.28M | $220.55M | $161.64M | $177.82M | $44.63M | $34.66M | $47.40M | $38.71M | $42.83M |
| Shareholders' Equity | $199.74M | $146.26M | $163.82M | $151.81M | $166.45M | $32.88M | $19.39M | $31.11M | $19.24M | $26.19M |
| Cash & Equivalents | $45.95M | $54.42M | $9.05M | $40.46M | $77.25M | $19.30M | $3.33M | $5.00M | $3.97M | $3.91M |
| Operating Cash Flow | -$9.14M | -$8.41M | -$10.29M | -$27.92M | -$21.18M | -$12.44M | -$12.94M | -$14.66M | -$5.83M | $4.66M |
| Capital Expenditures | $9.0K | $18.0K | $254.0K | $496.0K | $375.0K | $82.0K | $15.0K | $5.0K | $7.0K | $9.0K |
| Shares Outstanding | 39.28M | 39.92M | 40.34M | 39.56M | 38.16M | 23.68M | 17.38M | 17.37M | 13.67M | 13.18M |
| Dividends Per Share | $0.25 | — | — | — | — | — | — | — | — | — |